Carbamazepine 200 MG Oral Tablet — RxCUI 308979
RxNorm drug concept · Semantic clinical drug
RxCUI 308979
Semantic clinical drug · SCD
● Current RxNorm concept 47 FDA products
109 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI308979
Official nameCarbamazepine 200 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped47
Package NDCs mapped109
Reported Medicaid activity (SDUD)179,291 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Carbamazepine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats certain seizures in epilepsy and the severe facial nerve pain of trigeminal neuralgia. The brand Equetro is also used for manic or mixed episodes in bipolar I disorder. I...
- Take it by mouth exactly as prescribed. Many forms are taken with meals, and extended-release forms are usually twice a day. Carbatrol and Equetro capsules can be opened onto soft...
- Dizziness, drowsiness, unsteadiness, nausea and vomiting are most common, especially at the start. Be careful driving until you know how it affects you. Call your doctor if they do...
- Call for any rash, blisters or mouth sores, especially with fever. Also report fever, sore throat, easy bruising or bleeding, yellow skin or eyes, swelling of the face or lips, or...
🕸️ Concept Web — How Carbamazepine 200 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Carbamazepine 200 MG Oral Tablet
RxCUI 308979 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Carbamazepine
2002IN
-
Carbamazepine
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Epitol
203251BN -
Tegretol
203029BN
-
Epitol
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carbamazepine Oral Tablet
371260SCDF -
Carbamazepine Oral Product
1155760SCDG -
Carbamazepine Pill
1155761SCDG -
Carbamazepine Oral Tablet [Epitol]
367637SBDF -
Carbamazepine Oral Tablet [Tegretol]
367636SBDF -
Epitol Oral Product
1167624SBDG -
Epitol Pill
1167625SBDG -
Tegretol Oral Product
1180855SBDG - +4 more in this family
-
Carbamazepine Oral Tablet
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Carbamazepine 200 MG
315565SCDC -
Carbamazepine 200 MG Oral Tablet [Epitol]
211817SBD -
Carbamazepine 200 MG Oral Tablet [Tegretol]
308972SBD -
Carbamazepine 200 MG [Epitol]
572150SBDC -
Carbamazepine 200 MG [Tegretol]
565987SBDC
-
Carbamazepine 200 MG
Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Carbamazepine 200 MG
SCDC · 315565 -
Carbamazepine Oral Tablet
SCDF · 371260 -
Carbamazepine Oral Product
SCDG · 1155760 -
Carbamazepine Pill
SCDG · 1155761
Brand-Name Concepts
-
Carbamazepine 200 MG Oral Tablet [Epitol]
SBD · 211817 -
Carbamazepine 200 MG Oral Tablet [Tegretol]
SBD · 308972 -
Carbamazepine 200 MG [Epitol]
SBDC · 572150 -
Carbamazepine 200 MG [Tegretol]
SBDC · 565987 -
Carbamazepine Oral Tablet [Epitol]
SBDF · 367637 -
Carbamazepine Oral Tablet [Tegretol]
SBDF · 367636 -
Epitol Oral Product
SBDG · 1167624 -
Epitol Pill
SBDG · 1167625 -
Tegretol Oral Product
SBDG · 1180855 -
Tegretol Pill
SBDG · 1180856
📦 FDA Products & Package NDCs
47 products · 109 package NDCs
109 package NDCs map to RxCUI 308979 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-0090-01 | 100 TABLET in 1 BOTTLE (0093-0090-01) | Epitol | Teva Pharmaceuticals USA, Inc. | 1990-09-30 |
| 00093-0109-10 | 1000 TABLET in 1 BOTTLE (0093-0109-10) | Carbamazepine | Teva Pharmaceuticals USA, Inc. | 1990-09-30 |
| 00615-8545-39 | 30 TABLET in 1 BLISTER PACK (0615-8545-39) | Carbamazepine | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-10-09 |
| 00904-3854-61 | 100 BLISTER PACK in 1 CARTON (0904-3854-61) / 1 TABLET, CHE... | CARBAMAZEPINE | Major Pharmaceuticals | 2010-03-22 |
| 00904-6172-50 | 2000 TABLET in 1 BOTTLE (0904-6172-50) | CARBAMAZEPINE | Major Pharmaceuticals | 2010-09-20 |
| 00904-6172-61 | 100 BLISTER PACK in 1 CARTON (0904-6172-61) / 1 TABLET in 1... | CARBAMAZEPINE | Major Pharmaceuticals | 2010-09-20 |
| 29300-0382-01 | 100 TABLET in 1 BOTTLE (29300-382-01) | Carbamazepine | Unichem Pharmaceuticals (USA), Inc. | 2022-11-01 |
| 29300-0382-05 | 500 TABLET in 1 BOTTLE (29300-382-05) | Carbamazepine | Unichem Pharmaceuticals (USA), Inc. | 2022-11-01 |
| 29300-0382-10 | 1000 TABLET in 1 BOTTLE (29300-382-10) | Carbamazepine | Unichem Pharmaceuticals (USA), Inc. | 2022-11-01 |
| 43063-0328-12 | 12 TABLET in 1 BOTTLE, PLASTIC (43063-328-12) | Carbamazepine | PD-Rx Pharmaceuticals, Inc. | 2011-09-21 |
| 43063-0328-30 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-328-30) | Carbamazepine | PD-Rx Pharmaceuticals, Inc. | 2011-09-21 |
| 43353-0953-53 | 60 TABLET in 1 BOTTLE (43353-953-53) | CARBAMAZEPINE | Aphena Pharma Solutions - Tennessee, LLC | 2014-07-03 |
| 43353-0953-60 | 90 TABLET in 1 BOTTLE (43353-953-60) | CARBAMAZEPINE | Aphena Pharma Solutions - Tennessee, LLC | 2014-07-03 |
| 43353-0953-80 | 180 TABLET in 1 BOTTLE (43353-953-80) | CARBAMAZEPINE | Aphena Pharma Solutions - Tennessee, LLC | 2014-07-25 |
| 46708-0731-10 | 100 BLISTER PACK in 1 CARTON (46708-731-10) / 10 TABLET in... | CARBAMAZEPINE | Alembic Pharmaceuticals Limited | 2025-04-22 |
| 46708-0731-31 | 100 TABLET in 1 BOTTLE (46708-731-31) | CARBAMAZEPINE | Alembic Pharmaceuticals Limited | 2025-04-22 |
| 46708-0731-60 | 60 TABLET in 1 BOTTLE (46708-731-60) | CARBAMAZEPINE | Alembic Pharmaceuticals Limited | 2025-04-22 |
| 46708-0731-91 | 1000 TABLET in 1 BOTTLE (46708-731-91) | CARBAMAZEPINE | Alembic Pharmaceuticals Limited | 2025-04-22 |
| 50090-0384-00 | 100 TABLET in 1 BOTTLE (50090-0384-0) | Carbamazepine | A-S Medication Solutions | 2016-06-29 |
| 50090-5740-00 | 100 TABLET in 1 BOTTLE (50090-5740-0) | Carbamazepine | A-S Medication Solutions | 2021-09-29 |
| 50090-5740-03 | 28 TABLET in 1 BOTTLE (50090-5740-3) | Carbamazepine | A-S Medication Solutions | 2021-09-29 |
| 50268-0160-15 | 50 BLISTER PACK in 1 BOX (50268-160-15) / 1 TABLET in 1 BLI... | CARBAMAZEPINE | AvPAK | 2025-10-13 |
| 51407-0215-01 | 100 TABLET in 1 BOTTLE (51407-215-01) | Carbamazepine | Golden State Medical Supply, Inc. | 2019-05-09 |
| 51407-0215-10 | 1000 TABLET in 1 BOTTLE (51407-215-10) | Carbamazepine | Golden State Medical Supply, Inc. | 2019-05-09 |
| 51672-4005-01 | 100 TABLET in 1 BOTTLE (51672-4005-1) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 1996-10-03 |
| 51672-4005-02 | 500 TABLET in 1 BOTTLE (51672-4005-2) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 1996-10-03 |
| 51672-4005-03 | 1000 TABLET in 1 BOTTLE (51672-4005-3) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 1996-10-03 |
| 51672-4041-00 | 10 BLISTER PACK in 1 CARTON (51672-4041-0) / 10 TABLET, CHE... | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2000-10-24 |
| 51672-4041-01 | 100 TABLET, CHEWABLE in 1 BOTTLE (51672-4041-1) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2000-10-24 |
| 51672-4041-02 | 500 TABLET, CHEWABLE in 1 BOTTLE (51672-4041-2) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2000-10-24 |
| 51672-4041-09 | 5 BLISTER PACK in 1 CARTON (51672-4041-9) / 10 TABLET, CHEW... | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2000-10-24 |
| 51672-4047-04 | 1 BOTTLE in 1 CARTON (51672-4047-4) / 450 mL in 1 BOTTLE | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2025-08-15 |
| 51672-4050-01 | 100 TABLET, CHEWABLE in 1 BOTTLE (51672-4050-1) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2024-03-20 |
| 51672-4123-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-1) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2009-03-31 |
| 51672-4123-03 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-3) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2009-03-31 |
| 51672-4123-06 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-6) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2009-03-31 |
| 51672-4124-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4124-1) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2009-03-31 |
| 51672-4124-03 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4124-3) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2009-03-31 |
| 51672-4124-06 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4124-6) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2009-03-31 |
| 51672-4125-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-1) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2009-03-31 |
| 51672-4125-03 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-3) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2009-03-31 |
| 51672-4125-06 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-6) | Carbamazepine | Sun Pharmaceutical Industries, Inc. | 2009-03-31 |
| 55154-1396-00 | 10 BLISTER PACK in 1 BAG (55154-1396-0) / 1 TABLET in 1 BLI... | Carbamazepine | Cardinal Health 107, LLC | 2010-09-20 |
| 60290-0008-01 | 100 TABLET in 1 BOTTLE (60290-008-01) | Carbamazepine | Umedica Laboratories USA Inc. | 2020-04-21 |
| 60290-0008-02 | 1000 TABLET in 1 BOTTLE (60290-008-02) | Carbamazepine | Umedica Laboratories USA Inc. | 2020-04-21 |
| 60290-0034-02 | 100 TABLET in 1 BOTTLE (60290-034-02) | Carbamazepine | Umedica Laboratories USA Inc. | 2020-04-21 |
| 60290-0034-03 | 1000 TABLET in 1 BOTTLE (60290-034-03) | Carbamazepine | Umedica Laboratories USA Inc. | 2020-04-21 |
| 60429-0032-01 | 100 TABLET in 1 BOTTLE (60429-032-01) | CARBAMAZEPINE | Golden State Medical Supply, Inc. | 2014-03-07 |
| 60505-0183-00 | 100 TABLET in 1 BOTTLE (60505-0183-0) | CARBAMAZEPINE | Apotex Corp. | 2002-09-01 |
| 60505-0183-01 | 1000 TABLET in 1 BOTTLE (60505-0183-1) | CARBAMAZEPINE | Apotex Corp. | 2002-09-01 |
Observed labelers:
Bryant Ranch Prepack (23) ·
Sun Pharmaceutical Industries, Inc. (18) ·
Preferred Pharmaceuticals Inc. (10) ·
REMEDYREPACK INC. (8) ·
Alembic Pharmaceuticals Inc. (4) ·
Alembic Pharmaceuticals Limited (4)
· +19 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.